EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD74 Blockade Disrupts Endothelial Migrasome Signaling to Prevent Inflammatory Macrophage Differentiation and Inhibit Atherosclerotic Progression

Kangnan Zhang, Jiong Chen, Zhenhua Zhu, Hong Hu, Qinghui Zhang, Rongrong Jia, Na Wang, Shihao Xiang, Yong Zhou, Yuehong Wang, Ling Xu iD

Advanced Science · 2025-09 · 12 (35)

DOI: 10.1002/advs.202502838 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.06.2025. Verfasst von Kangnan Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Institue, Shanghai General Hospital, Shanghai Jiao tong University School of Medicine, Shanghai, 200080, China. Hauptthemen laut MEDLINE: Atherosclerosis, Histocompatibility Antigens Class II, Macrophages, Antigens, Differentiation, B-Lymphocyte. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial dysfunction and abnormal activation of the monocyte‐macrophage system form a critical loop in atherosclerosis. The role of migrasomes in endothelial‐immune interactions remains unclear. This study explores migrasome evolution in the atherosclerotic (AS) microenvironment, highlighting their function as amplifiers in the inflammatory cascade. Through analysis of ApoE −/‐ mouse models and single‐cell multi‐omics data, migrasome activity is mapped using Gene Set Variation Analysis (GSVA) algorithms. Co‐culture systems and anti‐Cluster of differentiation 74 (CD74) blocking experiments are employed to investigate immune‐metabolic reprogramming triggered by migrasome cargo signaling. Advanced imaging and functional studies demonstrated that the interaction between amyloid protein precursor (APP) ligands on endothelial cells and CD74 receptors on macrophages triggers endothelial cells to produce more migrasomes. The clinical relevance of these findings is confirmed through CD74 blocking experiments, which effectively disrupted migrasome‐mediated signaling and attenuated atherosclerotic progression. Importantly, migrasome content is positively correlated with the severity of atherosclerosis. These results fundamentally challenge existing paradigms of intercellular communication by establishing migrasomes as dual‐functional entities – serving both as biomarkers of endothelial stress and molecular drivers of immune microenvironment deterioration. The discovery of the “migrasome‐APP‐CD74” signaling network opens new avenues for developing organelle‐targeted therapies to interrupt the vicious cycle of vascular inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisHistocompatibility Antigens Class IIMacrophagesAntigens, Differentiation, B-LymphocyteCell DifferentiationEndothelial CellsAnimalsMiceSignal TransductionDisease ProgressionHumansInflammationDisease Models, AnimalMice, Inbred C57BL

Stichwörter der Autor:innen

APP‐CD74atheroscleroticendothelial cellmacrophagemigrasome

Substanzen

invariant chainHistocompatibility Antigens Class IIAntigens, Differentiation, B-Lymphocyte

Autor:innen und Institutionen

  • Clinical Research Institue, Shanghai General Hospital, Shanghai Jiao tong University School of Medicine, Shanghai, 200080, China.
  • Department of Gastroenterology, Tongren Hospital, Shanghai Jiao tong University School of Medicine, Shanghai, 200336, China.
  • Key Laboratory for Translational Research and Innovative Therapeutics of Gastrointestinal Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China.
  • Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai, 200001, China.
  • Department of Clinical laboratory, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China.
  • Department of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.

ORCID-Profile: Ling Xu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, K., Chen, J., Zhu, Z., Hu, H., Zhang, Q., Jia, R., Wang, N., Xiang, S., Zhou, Y., Wang, Y., & Xu, L. (2025). CD74 Blockade Disrupts Endothelial Migrasome Signaling to Prevent Inflammatory Macrophage Differentiation and Inhibit Atherosclerotic Progression. Advanced Science, 12(35). https://doi.org/10.1002/advs.202502838

Vancouver

Zhang K, Chen J, Zhu Z, Hu H, Zhang Q, Jia R, et al. CD74 Blockade Disrupts Endothelial Migrasome Signaling to Prevent Inflammatory Macrophage Differentiation and Inhibit Atherosclerotic Progression. Advanced Science. 2025;12(35). doi:10.1002/advs.202502838

BibTeX
@article{Zhang2025,
  author = {Zhang, Kangnan and Chen, Jiong and Zhu, Zhenhua and Hu, Hong and Zhang, Qinghui and Jia, Rongrong and Wang, Na and Xiang, Shihao and Zhou, Yong and Wang, Yuehong and Xu, Ling},
  title = {CD74 Blockade Disrupts Endothelial Migrasome Signaling to Prevent Inflammatory Macrophage Differentiation and Inhibit Atherosclerotic Progression},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {35},
  doi = {10.1002/advs.202502838}
}
Kostenlos starten →